Jens Nürnberger

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

Christophe Legendre, Christoph Licht, Petra Muus et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease

Gerd Walz, Klemens Budde, Marwan Mannaa et al. · New England Journal of Medicine · 2010 · 577 citations · Full text

Medicine, Nephrology, Renal Pathology +15

Augmentation index is associated with cardiovascular risk

Jens Nürnberger, Ayten Keflioglu-Scheiber, Anabelle M. Opazo Saez et al. · Journal of Hypertension · 2002 · 438 citations

Medicine, Cardiology, Internal Medicine +17

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

Jan T. Kielstein, Gernot Beutel, Susanne Fleig et al. · Nephrology Dialysis Transplantation · 2012 · 236 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14

Diastolic blood pressure is an important determinant of augmentation index and pulse wave velocity in young, healthy males

Jens Nürnberger, Sandra Dammer, Anabelle Opazo Saez et al. · Journal of Human Hypertension · 2003 · 133 citations

Medicine, Cardiology, Physiology +14